McDonough v. Secretary of Health and Human Services

In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

Filed: November 1, 2024 * * * * * * * * * * * * *

SHELBY MCDONOUGH, * parent of L.M., a minor, * *

Petitioner, * No. 24-243V * v. * Special Master Gowen *

SECRETARY OF HEALTH *

AND HUMAN SERVICES, * *

Respondent. * * * * * * * * * * * * * *

Christina Ciampolillo, Conway Homer, P.C., Boston, MA, for petitioner.

Meghan Murphy, U.S. Department of Justice, Washington, D.C., for respondent.

RULING ON ENTITLEMENT1

On February 16, 2024, Shelby McDonough, parent of L.M. (“petitioner”) filed a petition for compensation in the National Vaccine Injury Compensation Program (“the Program.”).2 Petition (ECF No.1). Petitioner alleges that as a result of L.M. receiving the diphtheria, tetanus, and acellular pertussis (“DTap”); measles, mumps, and rubella (“MMR”); varicella; and inactivated polio (“IPV”) vaccines (“the vaccines”) on September 17, 2021, L.M. suffered from cellulitis and subsequent scarring. Id.

On October 31, 2024, respondent filed the Rule 4(c) report recommending that compensation be awarded to petitioner. Respondent’s Rule 4c Report (“Res’t Rept.”) (ECF No. 18). Respondent stated, “Based on an evaluation of the medical evidence, and for the reasons explained below, it is respondent’s position that L.M. sustained cellulitis that was caused-in-fact by the vaccinations she received on September 17, 2021.” Id. at 1. Further, the Rule 4(c) states, “While petitioner has not established a Table injury, medical personnel at the Division of Injury Compensation Programs, Department of Health and Human Services (“DICP”), have reviewed the petition and supporting documentation filed in this case and concluded that L.M. developed cellulitis and residual hyperpigmentation on her left thigh, which in fact was more likely than not caused by administration of her vaccinations at the same location.” Id. at 3. No other causes for L.M.’s cellulitis have been identified and her skin changes, including residual hyperpigmentation, persisted at least twenty-six months after vaccination. Id. As the record stands, petitioner has satisfied all legal prerequisites for compensation under the Act. Id. A special master may determine whether a petitioner is entitled to compensation based upon the record. A hearing is not required 42 U.S.C. § 13; Vaccine Rule 8(d). In light of respondent’s recommendation and my own review of the record, petitioner has established that L.M. suffered from cellulitis and subsequent skin changes at the injection site as a result of receiving the vaccines on September 17, 2021, no other causes for L.M.’s cellulitis and residual skin changes have been identified, and L.M.’s residual symptoms have lasted for longer than six- months, satisfying the requirements of the Vaccine Act. Therefore, petitioner is entitled to compensation.3 This matter shall now proceed to the damages phase.

IT IS SO ORDERED. s/ Thomas L. Gowen Thomas L. Gowen Special Master